<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00785239</url>
  </required_header>
  <id_info>
    <org_study_id>17-00031</org_study_id>
    <nct_id>NCT00785239</nct_id>
  </id_info>
  <brief_title>CryoSpray Ablation(tm)Thoracic Patient Registry</brief_title>
  <official_title>CryoSpray Ablation(tm)Thoracic Patient Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CSA Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Reset Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>CSA Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to create a patient registry to collect and analyze information
      on subjects treated with the CryoSpray Ablation™ System post-510K approval.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed registry is a prospective, multi-center study of patients that are currently
      undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in
      this study.

      The study population consists of patients who are being treated with the CryoSpray Ablation™
      System for thoracic diseases. Enrolled subjects must have a signed consent form for data
      collection.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Business Reasons
  </why_stopped>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary objectives of the study are to enable analysis of patient outcomes 2 years following final treatment and estimate the effectiveness of the device in eradicating, decreasing and downgrading of the diseases.</measure>
    <time_frame>2 years post-treatment</time_frame>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Emphysema</condition>
  <condition>Chronic Bronchitis</condition>
  <condition>COPD</condition>
  <condition>Asthma</condition>
  <condition>Sarcoidosis</condition>
  <condition>Mesothelioma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of subjects treated with the CryoSpray Ablation™ System in
        the airway or for thoracic diseases.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients who are being treated with the CryoSpray Ablation™ System for lung and for
        thoracic diseases.

        Exclusion Criteria:

          -  Subjects with thoracic or airway obstructions and diseases who were not treated with
             the CryoSpray Ablation™ System.

          -  Subjects under the age of 18 years.

          -  Subjects unable to provide consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Krimsky, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Franklin Square Hospital Center</affiliation>
  </overall_official>
  <link>
    <url>http://www.csamedical.com</url>
    <description>For more information regarding CryoSpray Ablation</description>
  </link>
  <reference>
    <citation>Johnston MH, Eastone JA, Horwhat JD, Cartledge J, Mathews JS, Foggy JR. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc. 2005 Dec;62(6):842-8.</citation>
    <PMID>16301023</PMID>
  </reference>
  <reference>
    <citation>Johnston CM, Schoenfeld LP, Mysore JV, Dubois A. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest Endosc. 1999 Jul;50(1):86-92.</citation>
    <PMID>10385730</PMID>
  </reference>
  <reference>
    <citation>Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, Henrich R, Vieth M, Müller H, Seitz G, Stolte M. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000 Apr;118(4):670-7.</citation>
    <PMID>10734018</PMID>
  </reference>
  <reference>
    <citation>Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology. 1994 Sep;107(3):747-54.</citation>
    <PMID>8076761</PMID>
  </reference>
  <reference>
    <citation>Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol. 1997 Jan;92(1):27-31.</citation>
    <PMID>8995932</PMID>
  </reference>
  <reference>
    <citation>Johnston MH. Cryotherapy and other newer techniques. Gastrointest Endosc Clin N Am. 2003 Jul;13(3):491-504. Review.</citation>
    <PMID>14629105</PMID>
  </reference>
  <reference>
    <citation>Cash BD, Johnston LR, Johnston MH. Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol. 2007 Mar 16;5:34.</citation>
    <PMID>17367523</PMID>
  </reference>
  <reference>
    <citation>Pinsonneault C, Fortier J, Donati F. Tracheal resection and reconstruction. Can J Anaesth. 1999 May;46(5 Pt 1):439-55. Review.</citation>
    <PMID>10349923</PMID>
  </reference>
  <reference>
    <citation>Field JK, Youngson JH. The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection. Eur Respir J. 2002 Aug;20(2):464-79.</citation>
    <PMID>12212983</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2008</study_first_submitted>
  <study_first_submitted_qc>November 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2008</study_first_posted>
  <last_update_submitted>June 23, 2015</last_update_submitted>
  <last_update_submitted_qc>June 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malignant Airway Disease</keyword>
  <keyword>Benign Airway Disease</keyword>
  <keyword>Lung Cancer</keyword>
  <keyword>Emphysema</keyword>
  <keyword>Chronic Bronchitis</keyword>
  <keyword>COPD</keyword>
  <keyword>Asthma</keyword>
  <keyword>Sarcoidosis</keyword>
  <keyword>Mesothelioma</keyword>
  <keyword>CryoSpray Ablation</keyword>
  <keyword>Cryotherapy</keyword>
  <keyword>Cryospray</keyword>
  <keyword>Cryo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mesothelioma</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Bronchitis, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

